Applied UV (NASDAQ:AUVI) Posts Earnings Results, Misses Estimates By $0.01 EPS

Applied UV (NASDAQ:AUVI – Get Rating) posted its quarterly earnings data on Tuesday. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01), MarketWatch Earnings reports. The business had revenue of $10.65 million during the quarter. Applied UV had a negative return on equity of 52.10% and a negative net margin of 70.95%.

Applied UV Trading Up 10.0 %

Applied UV stock opened at $0.66 on Thursday. The stock has a market cap of $12.70 million, a P/E ratio of -0.43 and a beta of -0.97. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.07 and a quick ratio of 0.59. Applied UV has a 1 year low of $0.40 and a 1 year high of $4.20. The firm’s 50 day moving average price is $0.69 and its 200-day moving average price is $0.92.

Institutional Investors Weigh In On Applied UV

Several institutional investors and hedge funds have recently modified their holdings of AUVI. Millennium Management LLC bought a new stake in Applied UV in the second quarter worth $26,000. Northern Trust Corp bought a new position in Applied UV during the second quarter valued at $27,000. State Street Corp increased its position in Applied UV by 111.6% during the third quarter. State Street Corp now owns 27,684 shares of the company’s stock valued at $38,000 after acquiring an additional 14,600 shares during the last quarter. Renaissance Technologies LLC increased its position in Applied UV by 426.7% during the first quarter. Renaissance Technologies LLC now owns 70,831 shares of the company’s stock valued at $106,000 after acquiring an additional 57,384 shares during the last quarter. Finally, Advisor Group Holdings Inc. increased its position in Applied UV by 74.8% during the first quarter. Advisor Group Holdings Inc. now owns 75,804 shares of the company’s stock valued at $114,000 after acquiring an additional 32,440 shares during the last quarter. Institutional investors own 2.52% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, EF Hutton Acquisition Co. I lifted their price target on shares of Applied UV from $2.00 to $2.50 and gave the company a “buy” rating in a report on Monday, February 6th.

Applied UV Company Profile

(Get Rating)

Applied UV, Inc, through its subsidiaries, develops, acquires, and commercializes technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets in the United States, Canada, and Europe. It operates through Disinfection and Hospitality segments.